Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years. The percentage rose from 46 percent for children receiving a standard therapy to 66 percent for children receiving immunotherapy plus standard therapy, according to the study in the Sept. 30, 2010, New England Journal of Medicine. The randomized phase III clinical trial was coordinated by the Children’s Oncology Group (COG), a national consortium of researchers supported by the National Cancer Institute (NCI), part of the NIH.
COPD, Even When Mild, Limits Heart Function
January 21, 2010 | by
A common lung condition, COPD (chronic obstructive pulmonary disease) diminishes the heart’s ability to pump effectively even when the disease has no or mild symptoms, according to research published in the Jan. 21 issue of the New England Journal of Medicine. The study is the first time researchers have shown strong links between heart function and mild COPD. The research was funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.
Medicexchange: A Medical Imaging Resource
June 27, 2007 | by
The New England Journal of Medicine calls the development of body imaging one of the most important medical developments of the past 1,000 years [1]. Indeed, patient-specific information regarding disease diagnosis and progression is routinely obtained today using medical imaging.
Medicexchange is a medical imaging portal where you can find all the world’s leading medical imaging solutions in one place and offers a number of benefits for both radiology professionals and informed health consumers.
